Bottom line
STHAX vs QUAZX: the short answer
STHAX (AB Sustainable Thematic Credit Portfolio) and QUAZX (AB Small Cap Growth Portfolio) are both mutual funds.
But STHAX is far broader, holding 285 positions to 116 for QUAZX, so beyond the top names it adds exposure QUAZX doesn't have.
QUAZX is cheaper at 0.79% vs 0.85% — a difference of $6.00 a year per $10,000 invested.
Over one year, QUAZX returned +5.1% vs +2.5% for STHAX.
STHAX has a front-end sales load of up to 4.25%; the other does not.
Updated Nov 19, 2026
STHAX vs QUAZX side by side
| STHAX | QUAZX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Ab Bond | Ab Cap |
| Category | Core / Intermediate Bond | Small-Cap |
| Expense ratio | 0.85% | 0.79% |
| Annual cost per $10k | $85 | $79 |
| 10-yr cost on $10k (prospectus) | $1,471 | $989 |
| Max front load | 4.25% | 0% |
| 12b-1 fee | 0.25% | 0% |
| 1-yr return | +2.5% | +5.1% |
| 5-yr return (annualized) | — | −0.2% |
| 10-yr return (annualized) | — | +11.6% |
| Best quarter | +8.7% | — |
| Worst quarter | −8.7% | — |
| Net assets (fund) | $279.3M | $3.1B |
| Number of holdings | 285 | 116 |
| Portfolio turnover | 116% | 116% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
STHAX and QUAZX share none of their top holdings.
STHAX top 10
- Equinix Inc — 1.19%
- Nxp Bv/nxp Fdg/nxp USA — 1.16%
- Pfizer Inc — 0.95%
- Sekisui House US — 0.89%
- Autodesk Inc — 0.84%
- Salesforce Inc — 0.83%
- Xylem Inc — 0.83%
- Gilead Sciences Inc — 0.83%
- Mastercard Inc — 0.82%
- Prologis Lp — 0.71%
QUAZX top 10
- iShares Russell 2000 Growth ETF — 4.00%
- Alliance Bernstein — 3.98%
- Alliance Bernstein — 2.70%
- BrightSpring Health Services Inc — 1.76%
- Moog Inc — 1.75%
- ESCO Technologies Inc — 1.65%
- Chefs' Warehouse Inc/The — 1.52%
- Ultra Clean Holdings Inc — 1.52%
- Semtech Corp — 1.51%
- SharkNinja Inc — 1.50%
FAQ
What is the difference between STHAX and QUAZX?
Which is cheaper, STHAX or QUAZX?
Should I own both STHAX and QUAZX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.